JZP 361

Modify Date: 2024-01-08 09:32:38

JZP 361 Structure
JZP 361 structure
Common Name JZP 361
CAS Number 1680193-80-9 Molecular Weight 405.880
Density 1.4±0.1 g/cm3 Boiling Point 611.7±65.0 °C at 760 mmHg
Molecular Formula C22H20ClN5O Melting Point N/A
MSDS N/A Flash Point 323.8±34.3 °C

 Use of JZP 361


JZP-361 is a potent and reversible inhibitor of human recombinant MAGL (hMAGL, IC50=46 nM), and has almost 150-fold higher selectivity over human recombinant fatty acid amide hydrolase (hFAAH, IC50=7.24 μM) and 35-fold higher selectivity over human α/β-hydrolase-6 (hABHD6, IC50=1.79 μM). JZP-361 represents a dual-acting pharmacological tool possessing both MAGL inhibitory and antihistaminergic activities[1].

 Names

Name [4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinyl](1H-1,2,4-triazol-1-yl)methanone
Synonym More Synonyms

 JZP 361 Biological Activity

Description JZP-361 is a potent and reversible inhibitor of human recombinant MAGL (hMAGL, IC50=46 nM), and has almost 150-fold higher selectivity over human recombinant fatty acid amide hydrolase (hFAAH, IC50=7.24 μM) and 35-fold higher selectivity over human α/β-hydrolase-6 (hABHD6, IC50=1.79 μM). JZP-361 represents a dual-acting pharmacological tool possessing both MAGL inhibitory and antihistaminergic activities[1].
Related Catalog
Target

H1 Receptor:6.81 (pA2)

References

[1]. Jayendra Z Patel, et al. Loratadine analogues as MAGL inhibitors. Bioorg Med Chem Lett. 2015 Apr 1;25(7):1436-42.

 Chemical & Physical Properties

Density 1.4±0.1 g/cm3
Boiling Point 611.7±65.0 °C at 760 mmHg
Molecular Formula C22H20ClN5O
Molecular Weight 405.880
Flash Point 323.8±34.3 °C
Exact Mass 405.135651
LogP 3.88
Vapour Pressure 0.0±1.8 mmHg at 25°C
Index of Refraction 1.725

 Synonyms

[4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinyl](1H-1,2,4-triazol-1-yl)methanone
Methanone, [4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinyl]-1H-1,2,4-triazol-1-yl-